Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Cell Death & Disease
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. cell death & disease
  3. articles
  4. article
WWP2 underlies ROS-induced granulosa cell apoptosis by promoting ubiquitination of BAK in polycystic ovary syndrome
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 23 February 2026

WWP2 underlies ROS-induced granulosa cell apoptosis by promoting ubiquitination of BAK in polycystic ovary syndrome

  • Wenke Wang1 na1,
  • Wenjie Wu2 na1,
  • Mingjun Hao1 na1,
  • Shenshen Cui2 na1,
  • Siqi Zhao1 na1,
  • Jian-Fei Pei  ORCID: orcid.org/0000-0002-2312-46932,
  • Naijin Zhang  ORCID: orcid.org/0000-0003-3653-98013 &
  • …
  • Da Li  ORCID: orcid.org/0000-0002-4895-11854 

Cell Death & Disease , Article number:  (2026) Cite this article

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Apoptosis
  • Ubiquitylation

Abstract

Granulosa cell (GC) apoptosis is intrinsically linked to the ovarian dysfunction of polycystic ovary syndrome (PCOS). Although oxidative stress and apoptosis in GCs have been detected in PCOS patients, how reactive oxygen species (ROS) links to GC apoptosis in PCOS remains to be further elucidated. Here, by integrating public single-cell RNA-seq data with clinical GC sample validation, we found that the expression of the E3 ubiquitin ligase WWP2 was significantly reduced, whereas its role in PCOS has not been previously reported. Notably, we first demonstrated that WWP2 overexpression can effectively antagonize mitochondrial apoptosis and ROS in KGNs. Mechanistically, oxidative stress weakened the interaction between WWP2 and BAK and reduced WWP2 expression, thereby suppressing BAK ubiquitination at Lys113. This inhibition impaired proteasomal degradation and consequently increased BAK protein levels. Consistently, disrupting BAK ubiquitination (BAK-K113R mutant) or knocking down WWP2 facilitated KGN apoptosis, and genetic ablation of Wwp2 in PCOS mice further aggravated GC apoptosis and hormonal disturbances. This study elucidates the molecular mechanism by which oxidative stress modulates GC mitochondrial apoptosis through WWP2-mediated BAK ubiquitination, and establishes WWP2 as a potential therapeutic target for PCOS.

Similar content being viewed by others

Identification of molecular characteristics in polycystic ovary syndrome using single-cell and transcriptome analysis

Article Open access 23 January 2025

Evaluation of the p53 pathway in polycystic ovarian syndrome pathogenesis and apoptosis enhancement in human granulosa cells through transcriptome data analysis

Article Open access 19 July 2023

Identification of regulated cell death related genes in polycystic ovary syndrome using machine learning

Article Open access 26 September 2025

Data availability

All data relevant to the study are included in the article.

References

  1. Teede HJ, Moran LJ, Morman R, Gibson M, Dokras A, Berry L, et al. Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey. eClinicalMedicine. 2025;84:103287.

    Google Scholar 

  2. Mizgier M, Sansoni V, Więckowska B, Jarząbek-Bielecka G, Formanowicz D, Kędzia W, et al. The correlations between serum bone biomarkers and those related to metabolic and hormonal profile, low-grade inflammation and redox balance, in lean and overweight PCOS adolescent girls. Front Nutr. 2025;12:1477992.

    Google Scholar 

  3. Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22:687–708.

    Google Scholar 

  4. Moreira MV, Vale-Fernandes E, Albergaria IC, Alves MG, Monteiro MP. Follicular fluid composition and reproductive outcomes of women with polycystic ovary syndrome undergoing in vitro fertilization: A systematic review. Rev Endocr Metab Disord. 2023;24:1045–73.

    Google Scholar 

  5. Chen Y, Dai H, Mao F, Li Y, Feng R, Qian Y. Long noncoding RNA NONHSAT233728.1 promotes ROS accumulation and granulosa cell apoptosis by regulating the MAPK/ERK1/2 signaling pathway. FASEB J. 2025;39:e70681.

    Google Scholar 

  6. Liu Y, Jiang J-J, Du S-Y, Mu L-S, Fan J-J, Hu J-C, et al. Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction. Science. 2024;384:eadk5382.

    Google Scholar 

  7. Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2011;17:17–33.

    Google Scholar 

  8. Yu H, Zhang W, Wang D, Shi B, Zhu Y, Hu W, et al. Exposure to 6PPD-Q induces dysfunctions of ovarian granulosa cells: Its potential role in PCOS. J Hazard Mater. 2025;486:137037.

    Google Scholar 

  9. Huang J-C, Duan C-C, Jin S, Sheng C-B, Wang Y-S, Yue Z-P, et al. HB-EGF induces mitochondrial dysfunction via estrogen hypersecretion in granulosa cells dependent on cAMP-PKA-JNK/ERK-Ca2+-FOXO1 pathway. Int J Biol Sci. 2022;18:2047–59.

    Google Scholar 

  10. Bas D, Abramovich D, Hernandez F, Tesone M. Altered expression of Bcl-2 and Bax in follicles within dehydroepiandrosterone-induced polycystic ovaries in rats. Cell Biol Int. 2011;35:423–9.

    Google Scholar 

  11. Wang Z, Wu H, Chang X, Song Y, Chen Y, Yan Z, et al. CKMT1 deficiency contributes to mitochondrial dysfunction and promotes intestinal epithelial cell apoptosis via reverse electron transfer-derived ROS in colitis. Cell Death Dis. 2025;16:177.

    Google Scholar 

  12. Czabotar PE, Garcia-Saez AJ. Mechanisms of BCL-2 family proteins in mitochondrial apoptosis. Nat Rev Mol Cell Biol. 2023;24:732–48.

    Google Scholar 

  13. Cheng P, Hou Y, Bian M, Fang X, Liu Y, Rao Y, et al. Parkin-mediated ubiquitination inhibits BAK apoptotic activity by blocking its canonical hydrophobic groove. Commun Biol. 2023;6:1260.

    Google Scholar 

  14. Schweighofer SV, Jans DC, Keller-Findeisen J, Folmeg A, Ilgen P, Bates M, et al. Endogenous BAX and BAK form mosaic rings of variable size and composition on apoptotic mitochondria. Cell Death Differ. 2024;31:469–78.

    Google Scholar 

  15. Hockings C, Alsop AE, Fennell SC, Lee EF, Fairlie WD, Dewson G, et al. Mcl-1 and Bcl-xL sequestration of bak confers differential resistance to BH3-only proteins. Cell Death Differ. 2018;25:721–34.

    Google Scholar 

  16. Bernardini JP, Brouwer JM, Tan IK, Sandow JJ, Huang S, Stafford CA, et al. Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy. EMBO J. 2019;38:e99916.

    Google Scholar 

  17. Huang AS, Chin HS, Reljic B, Djajawi TM, Tan IKL, Gong J-N, et al. Mitochondrial E3 ubiquitin ligase MARCHF5 controls BAK apoptotic activity independently of BH3-only proteins. Cell Death Differ. 2023;30:632–46.

    Google Scholar 

  18. Someya S, Xu J, Kondo K, Ding D, Salvi RJ, Yamasoba T, et al. Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis. Proc Natl Acad Sci USA. 2009;106:19432–7.

    Google Scholar 

  19. Wu H, Zhao B, Yao Q, Kang J. Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes. J Ovarian Res. 2023;16:207.

    Google Scholar 

  20. Zhang N, Zhang Y, Xu J, Wang P, Wu B, Lu S, et al. α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure. Cell Res. 2023;33:679–98.

    Google Scholar 

  21. Li T, Zhang T, Gao H, Liu R, Gu M, Yang Y, et al. Tempol ameliorates polycystic ovary syndrome through attenuating intestinal oxidative stress and modulating of gut microbiota composition-serum metabolites interaction. Redox Bio. 2021;41:101886.

    Google Scholar 

  22. You S, Xu J, Yin Z, Wu B, Wang P, Hao M, et al. Down-regulation of WWP2 aggravates type 2 diabetes mellitus-induced vascular endothelial injury through modulating ubiquitination and degradation of DDX3X. Cardiovasc Diabetol. 2023;22:107.

    Google Scholar 

  23. Pervushin NV, Nilov DK, Zhivotovsky B, Kopeina GS. Bcl-2 modifying factor (bmf): ‘a mysterious stranger’ in the bcl-2 family proteins. Cell Death Differ. 2025 https://doi.org/10.1038/s41418-025-01562-z.

  24. Holloway A, Simmonds M, Azad A, Fox JL, Storey A. Resistance to UV-induced apoptosis by β-HPV5 E6 involves targeting of activated BAK for proteolysis by recruitment of the HERC1 ubiquitin ligase. Int J Cancer. 2015;136:2831–43.

    Google Scholar 

  25. Iyer S, Bell F, Westphal D, Anwari K, Gulbis J, Smith BJ, et al. Bak apoptotic pores involve a flexible C-terminal region and juxtaposition of the C-terminal transmembrane domains. Cell Death Differ. 2015;22:1665–75.

    Google Scholar 

  26. You S, Xu J, Guo Y, Guo X, Zhang Y, Zhang N, et al. E3 ubiquitin ligase WWP2 as a promising therapeutic target for diverse human diseases. Mol Aspects Med. 2024;96:101257.

    Google Scholar 

  27. Cosentino K, Hertlein V, Jenner A, Dellmann T, Gojkovic M, Peña-Blanco A, et al. The interplay between BAX and BAK tunes apoptotic pore growth to control mitochondrial-DNA-mediated inflammation. Mol Cell. 2022;82:933–.e9.

    Google Scholar 

  28. Shang F, Taylor A. Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radic Biol Med. 2011;51:5–16.

    Google Scholar 

  29. Delrue C, Speeckaert MM. Renal implications of dysregulated protein homeostasis: insights into ubiquitin-proteasome and autophagy systems. Biomolecules. 2025;15:349.

    Google Scholar 

  30. Yang L-K, Ma W-J, Wang X, Chen H-R, Jiang Y-N, Sun H. Apoptosis in polycystic ovary syndrome: mechanisms and therapeutic implications. Life Sci. 2025;363:123394.

    Google Scholar 

  31. Yan H, Wang L, Zhang G, Li N, Zhao Y, Liu J, et al. Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: from mechanisms to therapeutic strategies. Reprod Biol Endocrinol. 2024;22:159.

    Google Scholar 

  32. Li Y, Song H, Xu J, Wang Y, Bai L, Wang H, et al. TIGAR relieves PCOS by inhibiting granulosa cell apoptosis and oxidative stress through activating Nrf2. Mol Cell Endocrinol. 2024;594:112381.

    Google Scholar 

  33. Canipari R. Oocyte-granulosa cell interactions. Hum Reprod Update. 2000;6:279–89.

    Google Scholar 

  34. Wang H. The role of granulosa cells in oocyte development and aging: mechanisms and therapeutic opportunities. Semin Cell Dev Biol. 2025;171:103614.

    Google Scholar 

  35. Gong Y, Luo S, Fan P, Zhu H, Li Y, Huang W. Growth hormone activates PI3K/akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome. Reprod Biol Endocrinol. 2020;18:121.

    Google Scholar 

  36. Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014;15:49–63.

    Google Scholar 

  37. Sun T, Liu Z, Yang Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 2020;19:146.

    Google Scholar 

  38. Liu X, Sun C, Zou K, Li C, Chen X, Gu H, et al. Novel PGK1 determines SKP2-dependent AR stability and reprograms granular cell glucose metabolism facilitating ovulation dysfunction. eBioMedicine. 2020;61:103058.

    Google Scholar 

  39. Zhang N, Zhang Y, Qian H, Wu S, Cao L, Sun Y. Selective targeting of ubiquitination and degradation of PARP1 by E3 ubiquitin ligase WWP2 regulates isoproterenol-induced cardiac remodeling. Cell Death Differ. 2020;27:2605–19.

    Google Scholar 

Download references

Funding

This research was supported by Noncommunicable Chronic Diseases-National Science and Technology Major Project (2025ZD0547800), the National Natural Science Foundation of China (82371647, 82470283, 82271615), National Key Research and Development Program (No. 2024YFC2706900), the Science Foundation for Outstanding Youth of Liaoning Province (No. 2024JH3/50100023), Scientific Research Fund of Liaoning Provincial Education Department (No. LJ222410159094) and the Liaoning Revitalization Talents Program (XLYC2403104).

Author information

Author notes
  1. These authors contributed equally: Wenke Wang, Wenjie Wu, Mingjun Hao, Shenshen Cui, Siqi Zhao.

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Center of Reproductive Medicine, NHC Key Laboratory of Advanced Reproductive Medicine and Fertility (China Medical University), National Health Commission, Shengjing Hospital of China Medical University, Shenyang, China

    Wenke Wang, Mingjun Hao & Siqi Zhao

  2. Department of Medical Genetics, China Medical University, Shenyang, China

    Wenjie Wu, Shenshen Cui & Jian-Fei Pei

  3. Department of Cardiology, The First Hospital of China Medical University, Institute of Health Sciences, China Medical University, Shenyang, China

    Naijin Zhang

  4. Department of Obstetrics and Gynecology, Center of Reproductive Medicine, NHC Key Laboratory of Advanced Reproductive Medicine and Fertility (China Medical University), National Health Commission, Shengjing Hospital of China Medical University, Key Laboratory of Reproductive Dysfunction Diseases and Fertility Remodeling of Liaoning Province, Shenyang, China

    Da Li

Authors
  1. Wenke Wang
    View author publications

    Search author on:PubMed Google Scholar

  2. Wenjie Wu
    View author publications

    Search author on:PubMed Google Scholar

  3. Mingjun Hao
    View author publications

    Search author on:PubMed Google Scholar

  4. Shenshen Cui
    View author publications

    Search author on:PubMed Google Scholar

  5. Siqi Zhao
    View author publications

    Search author on:PubMed Google Scholar

  6. Jian-Fei Pei
    View author publications

    Search author on:PubMed Google Scholar

  7. Naijin Zhang
    View author publications

    Search author on:PubMed Google Scholar

  8. Da Li
    View author publications

    Search author on:PubMed Google Scholar

Contributions

Wenke Wang: Writing - original draft, Writing - review & editing, Software, Methodology, Formal analysis, Data curation. Wenjie Wu: Investigation, Software, Formal analysis, Validation, Methodology, Data curation. Mingjun Hao: Writing - original draft, Software, Formal analysis, Validation, Data curation. Shenshen Cui: Writing - review & editing, Methodology, Formal analysis, Data curation. Siqi Zhao: Resources, Investigation, Data curation. Jian-Fei Pei: Writing - review & editing, Visualization, Validation, Supervision, Conceptualization. Naijin Zhang: Writing - original draft, Supervision, Funding acquisition, Conceptualization. Da Li: Writing - review & editing, Writing - original draft, Visualization, Validation, Supervision, Project administration, Methodology, Investigation, Funding acquisition, Formal analysis, Data curation, Conceptualization.

Corresponding authors

Correspondence to Jian-Fei Pei, Naijin Zhang or Da Li.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

All experimental procedures involving human participants and animals were performed in accordance with the relevant guidelines and regulations. The human study was approved by the Ethics Committee of Shengjing Hospital, China Medical University, Shenyang (Approval No. SZCS2025016), and informed consent was obtained from all IVF participants for the collection of ovarian granulosa cells. The animal study protocol was approved by the Animal Ethics Committee of China Medical University (License number CMU2023296).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Edited by Professor Mauro Piacentini

Supplementary information

Supplemental Figures and Figure Legends

Supplemental Table 1

Supplemental Table 2

Full and uncropped western blots

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, W., Wu, W., Hao, M. et al. WWP2 underlies ROS-induced granulosa cell apoptosis by promoting ubiquitination of BAK in polycystic ovary syndrome. Cell Death Dis (2026). https://doi.org/10.1038/s41419-026-08500-y

Download citation

  • Received: 07 August 2025

  • Revised: 11 January 2026

  • Accepted: 10 February 2026

  • Published: 23 February 2026

  • DOI: https://doi.org/10.1038/s41419-026-08500-y

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Videos
  • Collections
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • About the Editors
  • Open access publishing
  • Contact
  • For Advertisers
  • Press Releases
  • About the Partner
  • Upcoming Conferences

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Cell Death & Disease (Cell Death Dis)

ISSN 2041-4889 (online)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited